Drug Free Solution, Inc. (DSOL)
- Previous Close
0.0002 - Open
0.0002 - Bid --
- Ask --
- Day's Range
0.0002 - 0.0002 - 52 Week Range
0.0002 - 0.0002 - Volume
1,456 - Avg. Volume
0 - Market Cap (intraday)
503,201 - Beta (5Y Monthly) -6.79
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Drug Free Solution, Inc., a lifestyle company, delivers proprietary emotional wellness technology, known as Living Breath Process. Its Living Breath Process is a three-step process that combines self-analysis, breath, and language addressing various markets, including addiction/prevention, self help, emotional wellness, and lifestyle. The company also offers the Living Breath Series of programs with products, education, and services. Its Living Breath Project, through protocols, lifestyle enhancement products, training, and education, focuses on creating community wellness centers, wellness homes, and correctional facility support networks and centers that combine various offerings to diminish addiction and incarceration rates in the United States. The company was formerly known as Living Breath Project, Inc. and changed its name to Drug Free Solution, Inc. in January 2014. Drug Free Solution, Inc. is based in El Segundo, California.
www.drugfreesolution.com--
Full Time Employees
May 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: DSOL
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DSOL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DSOL
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
236.11
Enterprise Value/EBITDA
-0.58
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-1,270.07%
Return on Equity (ttm)
--
Revenue (ttm)
2.1k
Net Income Avi to Common (ttm)
-867.71k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
7.12k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-195.44k
Company Insights: DSOL
DSOL does not have Company Insights